China Life Insurance Company Limited
CN¥34.60-CN¥0.47 (-1.34%)
China Life Insurance Company Limited’s quoted price sits in the lower half of its reported 52-week range, 33.36% below the high.
SHZ · 000503.SZ · CNY
Stock price, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
China Reform Health Management and Services Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.09% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
China Reform Health Management and Services Group Co., Ltd.’s next earnings report is currently expected on Apr 26, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow China Reform Health Management and Services Group Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
China Reform Health Management and Services Group Co., Ltd. offers medical insurance management services in China. It provides services of medical insurance funds, medical quality and safety, drug and device supervision, and internet health protection. It is also involved in the pharmaceutical and medical business. China Reform Health Management and Services Group Co., Ltd. was formerly known as SeaRainbow Holding Corp. and changed its name to China Reform Health Management and Services Group Co., Ltd. in May 2018. The company was founded in 1987 and is based in Beijing, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:31 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 |
|---|
| Apr 24, 2025 |
| CN¥0.02 |
| CN¥156.72M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥34.60-CN¥0.47 (-1.34%)
China Life Insurance Company Limited’s quoted price sits in the lower half of its reported 52-week range, 33.36% below the high.
CN¥142.01-CN¥0.88 (-0.62%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.2% below the high.
CN¥48.46-CN¥0.16 (-0.33%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.39% below the high.
CN¥7.42-CN¥0.11 (-1.46%)
The People's Insurance Company (Group) of China Limited’s quoted price sits in the lower half of its reported 52-week range, 27.11% below the high.
CN¥30.66-CN¥0.09 (-0.29%)
China Pacific Insurance (Group) Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.64% below the high.
HK$50.70+HK$0.05 (+0.1%)
Jiangsu Hengrui Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.37% below the high.
CN¥181.75+CN¥2.75 (+1.54%)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 16.2% below the high.
CN¥50.25-CN¥0.30 (-0.59%)
New China Life Insurance Company Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.47% below the high.